These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8499437)

  • 1. Modularity of protein function: chimeric interleukin 1 beta s containing specific protease inhibitor loops retain function of both molecules.
    Wolfson AJ; Kanaoka M; Lau F; Ringe D; Young P; Lee J; Blumenthal J
    Biochemistry; 1993 May; 32(20):5327-31. PubMed ID: 8499437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insertion of an elastase-binding loop into interleukin-1 beta.
    Wolfson AJ; Kanaoka M; Lau FT; Ringe D
    Protein Eng; 1991 Feb; 4(3):313-7. PubMed ID: 1857715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition spectra of the human pancreatic endopeptidases.
    Mallory PA; Travis J
    Am J Clin Nutr; 1975 Aug; 28(8):823-30. PubMed ID: 1080008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional study of an Anemonia elastase inhibitor, a "nonclassical" Kazal-type inhibitor from Anemonia sulcata.
    Hemmi H; Kumazaki T; Yoshizawa-Kumagaye K; Nishiuchi Y; Yoshida T; Ohkubo T; Kobayashi Y
    Biochemistry; 2005 Jul; 44(28):9626-36. PubMed ID: 16008348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly effective protease inhibitors from variants of human pancreatic secretory trypsin inhibitor (hPSTI): an assessment of 3-D structure-based protein design.
    Szardenings M; Vasel B; Hecht HJ; Collins J; Schomburg D
    Protein Eng; 1995 Jan; 8(1):45-52. PubMed ID: 7770451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
    Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
    Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two reactive site locations and structure-function study of the arrowhead proteinase inhibitors, A and B, using mutagenesis.
    Xie ZW; Luo MJ; Xu WF; Chi CW
    Biochemistry; 1997 May; 36(19):5846-52. PubMed ID: 9153425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory specificity change of the ovomucoid third domain of the silver pheasant upon introduction of an engineered Cys14-Cys39 bond.
    Hemmi H; Kumazaki T; Yamazaki T; Kojima S; Yoshida T; Kyogoku Y; Katsu M; Shinohara F; Yokosawa H; Miura K; Kobayashi Y
    Biochemistry; 2003 Mar; 42(9):2524-34. PubMed ID: 12614146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for dual inhibitory role of tamarind Kunitz inhibitor (TKI) against factor Xa and trypsin.
    Patil DN; Chaudhary A; Sharma AK; Tomar S; Kumar P
    FEBS J; 2012 Dec; 279(24):4547-64. PubMed ID: 23094997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refined X-ray crystal structures of the reactive site modified ovomucoid inhibitor third domains from silver pheasant (OMSVP3*) and from Japanese quail (OMJPQ3*).
    Musil D; Bode W; Huber R; Laskowski M; Lin TY; Ardelt W
    J Mol Biol; 1991 Aug; 220(3):739-55. PubMed ID: 1870129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What can the structures of enzyme-inhibitor complexes tell us about the structures of enzyme substrate complexes?
    Laskowski M; Qasim MA
    Biochim Biophys Acta; 2000 Mar; 1477(1-2):324-37. PubMed ID: 10708867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loop substitution as a tool to identify active sites of interleukin-1 beta.
    Palla E; Bensi G; Solito E; Buonamassa DT; Fassina G; Raugei G; Spano F; Galeotti C; Mora M; Domenighini M
    J Biol Chem; 1993 Jun; 268(18):13486-92. PubMed ID: 7685764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of receptor binding sites on IL-1 beta by reconstruction of IL-1ra-like domains.
    Boraschi D; Bossù P; Ruggiero P; Tagliabue A; Bertini R; Macchia G; Gasbarro C; Pellegrini L; Melillo G; Ulisse E; Visconti U; Bizzarri C; Del Grosso E; Mackay AR; Frascotti G; Frigerio F; Grifantini R; Grandi G
    J Immunol; 1995 Nov; 155(10):4719-25. PubMed ID: 7594472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
    Krystek S; Stouch T; Novotny J
    J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutational analysis of receptor binding sites of interleukin-1 beta: differences in binding of human interleukin-1 beta muteins to human and mouse receptors.
    Grütter MG; van Oostrum J; Priestle JP; Edelmann E; Joss U; Feige U; Vosbeck K; Schmitz A
    Protein Eng; 1994 May; 7(5):663-71. PubMed ID: 8073036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two variants of the major serine protease inhibitor from the sea anemone Stichodactyla helianthus, expressed in Pichia pastoris.
    García-Fernández R; Ziegelmüller P; González L; Mansur M; Machado Y; Redecke L; Hahn U; Betzel C; Chávez Mde L
    Protein Expr Purif; 2016 Jul; 123():42-50. PubMed ID: 26993255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of trypsin-turkey egg white inhibitor complex.
    Ibrahim BS; Pattabhi V
    Biochem Biophys Res Commun; 2004 Jan; 313(1):8-16. PubMed ID: 14672690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Kazal-type trypsin inhibitor from the protochordate Ciona intestinalis.
    Odum L; Bundgaard JR; Johnsen AH
    Eur J Biochem; 1999 Feb; 259(3):872-6. PubMed ID: 10092876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single mutation at P1 of a chymotrypsin inhibitor changes it to a trypsin inhibitor: X-ray structural (2.15 A) and biochemical basis.
    Khamrui S; Dasgupta J; Dattagupta JK; Sen U
    Biochim Biophys Acta; 2005 Aug; 1752(1):65-72. PubMed ID: 16081330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Erythrina protease inhibitor: interactions with tissue plasminogen activator.
    Heussen-Schemmer C; Merrifield EH; Dowdle EB
    Thromb Haemost; 1991 Aug; 66(2):226-31. PubMed ID: 1771616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.